Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06479161 · ClinicalTrials.gov registry record · Phase 2
Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty
A Phase 2 study of Postoperative Pain, sponsored by Matthew Grosso, MD.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06479161 is a Phase 2 study of Postoperative Pain that is actively recruiting participants, run by Matthew Grosso, MD. The registered enrollment target is 80 participants, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06479161, a Phase 2 study of Postoperative Pain, is actively recruiting participants, sponsored by Matthew Grosso, MD.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to evaluate postoperative pain. Secondary outcomes evaluated in this study will include range of motion (ROM), opioid consumption, and ambulation. Each outcome measure will be evaluated, oral tranexamic acid (TXA) in the experiment arm and placebo in the control arm, after total knee arthroplasty (TKA) at postoperative days 0-3, and weeks 1, 2, 6, and 12.
Conditions Studied
Interventions
- DRUG Tranexamic acid
Study Locations (1)
Connecticut
- Trinity Health Of New England/CT Joint Replacement Institute - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-06-10 |
| Est. Completion | 2025-03-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06479161
The ClinicalTrials.gov registry entry for NCT06479161 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (65% lower). The listed sponsor is Matthew Grosso, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which Tranexamic acid is the first listed.
NCT06479161 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06479161 about?
NCT06479161 is a clinical study titled "Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty". The primary purpose of this study is to evaluate postoperative pain. Secondary outcomes evaluated in this study will include range of motion (ROM), opioid consumption, and ambulation. Each outcome measure will be evaluated, oral tranexamic acid (TXA) in the experiment arm and placebo in the control ...
What is the current status of trial NCT06479161?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2024-06-10. Estimated completion is 2025-03-30.
What conditions does trial NCT06479161 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT06479161?
The interventions under investigation include: Tranexamic acid (DRUG).
Who is sponsoring clinical trial NCT06479161?
This trial is sponsored by Matthew Grosso, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06479161 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
RECRUITING · Phase 2
-
Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy
RECRUITING · Phase 2
-
Local Anesthetics on Postsurgical Analgesia Following Posterior Colporrhaphy
COMPLETED · Phase 2
-
Phase 2 Bunionectomy HTX-011 Administration Study
COMPLETED · Phase 2
-
Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy
COMPLETED · Phase 2
-
Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.